Last reviewed · How we verify
alpha-glucosidase inhibitors — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
alpha-glucosidase inhibitors (alpha-glucosidase inhibitors) — Sanofi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| alpha-glucosidase inhibitors TARGET | alpha-glucosidase inhibitors | Sanofi | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- alpha-glucosidase inhibitors CI watch — RSS
- alpha-glucosidase inhibitors CI watch — Atom
- alpha-glucosidase inhibitors CI watch — JSON
- alpha-glucosidase inhibitors alone — RSS
Cite this brief
Drug Landscape (2026). alpha-glucosidase inhibitors — Competitive Intelligence Brief. https://druglandscape.com/ci/alpha-glucosidase-inhibitors. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab